Insights On Trial Design
-
Reassure Patients About Benefits Of Clinical Trial Participation
10/29/2025
Gaining a patient’s trust is the first step to trial participation. Find out how to address this in From Cautious to Committed, the first of a three-part webinar series covering strategies across the patient recruitment continuum.
-
How Adaptive Design Accelerates Early‑Phase NSCLC Development
5/22/2026
Adaptive trial designs and an adaptive mindset enable non-small cell lung cancer (NSCLC) sponsors to optimize dose, respond to evolving expectations, and accelerate early‑phase development.
-
Understanding Subjective Outcome Measures In HAP Studies
4/28/2026
Understanding how a participant "feels" is essential for drug safety. Explore how subjective measures and specialized training provide the data needed to evaluate human abuse potential.
-
Why Are Sponsors Prioritizing Ophthalmology Clinical Trials?
3/18/2026
Explore how demographic shifts and retinal innovation are transforming ophthalmology trials, and why operational precision is the key to protecting data integrity in this high-growth sector.
-
Leveraging Biomarkers In Early PK/PD Studies
7/9/2025
Integrating biomarkers into early clinical studies is crucial to determine whether a new therapy engages its biological target, triggers the intended PD effects, and shows early signs of efficacy.
-
How To Improve Patient Outcomes Using eSource Software In Clinical Trials
8/11/2025
As the demand for patient-centric clinical trials grows, eSource platforms will play an increasingly vital role in facilitating efficient, compliant, and innovative research methodologies.
-
Why Operational Expertise Defines Great Clinical Trial Services
9/4/2026
Great trial technology isn't enough on its own. See why the operational expertise behind it can make or break your study's success.
-
Running Flexible Trials In The Heart Of Patient Communities
5/14/2025
Bringing clinical research closer to patients by running flexible trials in the heart of their own communities increases access to research for both patients and sites.
-
5 Questions To Ask Before Selecting A Randomization Partner
5/12/2026
Choose the right IRT partner for complex master protocols. Learn how adaptive randomisation expertise and flexible technology reduce disruption and keep trials execution-ready.
-
Improving The eCOA Experience
1/25/2026
Discover how template-driven builds and reuse can slash eCOA timelines by 50% while solving the licensing and translation hurdles that delay First Patient In.